1. 2021
  2. The CXCL12gamma chemokine immobilized by heparan sulfate on stromal niche cells controls adhesion and mediates drug resistance in multiple myeloma

    Ren, Z., Lantermans, H., Kuil, A., Kraan, W., Arenzana-Seisdedos, F., Kersten, M. J., Spaargaren, M. & Pals, S. T., 1 Dec 2021, In: JOURNAL OF HEMATOLOGY & ONCOLOGY. 14, 1, 11.

    Research output: Contribution to journalArticleAcademicpeer-review

  3. 2020
  4. Identification of the SRC-family tyrosine kinase HCK as a therapeutic target in mantle cell lymphoma

    Lantermans, H. C., Minderman, M., Kuil, A., Kersten, M-J., Pals, S. T. & Spaargaren, M., 2020, (E-pub ahead of print) In: Leukemia.

    Research output: Contribution to journalArticleAcademicpeer-review

  5. 2017
  6. Cell lines generated from a chronic lymphocytic leukemia mouse model exhibit constitutive Btk and Akt signaling

    Singh, S. P., Pillai, S. Y., de Bruijn, M. J. W., Stadhouders, R., Corneth, O. B. J., van den Ham, H. J., Muggen, A., van Ijcken, W., Slinger, E., Kuil, A., Spaargaren, M., Kater, A. P., Langerak, A. W. & Hendriks, R. W., 2017, In: Oncotarget. 8, 42, p. 71981-71995

    Research output: Contribution to journalArticleAcademicpeer-review

  7. 2016
  8. Ibrutinib and idelalisib target B cell receptor- but not CXCL12/CXCR4-controlled integrin-mediated adhesion in Waldenström macroglobulinemia

    de Rooij, M. F. M., Kuil, A., Kraan, W., Kersten, M. J., Treon, S. P., Pals, S. T. & Spaargaren, M., 2016, In: Haematologica. 101, 3, p. e111-e115

    Research output: Contribution to journalComment/Letter to the editorAcademic

  9. The pan phosphoinositide 3-kinase/mammalian target of rapamycin inhibitor SAR245409 (voxtalisib/XL765) blocks survival, adhesion and proliferation of primary chronic lymphocytic leukemia cells

    Thijssen, R., ter Burg, J., van Bochove, G. G. W., de Rooij, M. F. M., Kuil, A., Jansen, M. H., Kuijpers, T. W., Baars, J. W., Virone-Oddos, A., Spaargaren, M., Egile, C., van Oers, M. H. J., Eldering, E., Kersten, M. J. & Kater, A. P., 2016, In: Leukemia. 30, 2, p. 337-345

    Research output: Contribution to journalArticleAcademicpeer-review

  10. The pan phosphoinositide 3-kinase/mammalian target of rapamycin inhibitor SAR245409 ( voxtalisib/XL765) blocks survival, adhesion and proliferation of primary chronic lymphocytic leukemia cells (Vol 30, pg 337, 2016)

    Thijssen, R., ter Burg, J., van Bochove, G. G. W., de Rooij, M. F. M., Kuil, A., Jansen, M. H., Kuijpers, T. W., Baars, J. W., Virone-Oddos, A., Spaargaren, M., Egile, C., van Oers, M. H. J., Eldering, E., Kersten, M. J. & Kater, A. P., 2016, In: Leukemia. 30, 9, p. 1963

    Research output: Contribution to journalComment/Letter to the editorAcademic

  11. 2015
  12. Ibrutinib and idelalisib synergistically target BCR-controlled adhesion in MCL and CLL: a rationale for combination therapy

    de Rooij, M. F. M., Kuil, A., Kater, A. P., Kersten, M. J., Pals, S. T. & Spaargaren, M., 2015, In: Blood. 125, 14, p. 2306-2309

    Research output: Contribution to journalComment/Letter to the editorAcademic

  13. 2013
  14. Egress of CD19(+)CD5(+) cells into peripheral blood following treatment with the Bruton tyrosine kinase inhibitor ibrutinib in mantle cell lymphoma patients

    Chang, B. Y., Francesco, M., de Rooij, M. F. M., Magadala, P., Steggerda, S. M., Huang, M. M., Kuil, A., Herman, S. E. M., Chang, S., Pals, S. T., Wilson, W., Wiestner, A., Spaargaren, M., Buggy, J. J. & Elias, L., 2013, In: Blood. 122, 14, p. 2412-2424

    Research output: Contribution to journalArticleAcademicpeer-review

  15. 2012
  16. The clinically active BTK inhibitor PCI-32765 targets B-cell receptor- and chemokine-controlled adhesion and migration in chronic lymphocytic leukemia

    de Rooij, M. F. M., Kuil, A., Geest, C. R., Eldering, E., Chang, B. Y., Buggy, J. J., Pals, S. T. & Spaargaren, M., 2012, In: Blood. 119, 11, p. 2590-2594

    Research output: Contribution to journalArticleAcademicpeer-review

Previous 1 2 3 Next

ID: 68261